These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37810765)

  • 21. Decreasing subthalamic deep brain stimulation frequency reverses cognitive interference during gait initiation in Parkinson's disease.
    Varriale P; Collomb-Clerc A; Van Hamme A; Perrochon A; Kemoun G; Sorrentino G; George N; Lau B; Karachi C; Welter ML
    Clin Neurophysiol; 2018 Nov; 129(11):2482-2491. PubMed ID: 30100532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of subthalamic deep brain stimulation on sleep and other non-motor symptoms in Parkinson's disease.
    Dulski J; Schinwelski M; Konkel A; Grabowski K; Libionka W; Wąż P; Sitek EJ; Sławek J
    Parkinsonism Relat Disord; 2019 Jul; 64():138-144. PubMed ID: 30975618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation.
    Burdick AP; Foote KD; Wu S; Bowers D; Zeilman P; Jacobson CE; Ward HE; Okun MS
    Neuroimage; 2011 Jan; 54 Suppl 1():S227-32. PubMed ID: 20932923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep brain stimulation improves movement amplitude but not hastening of repetitive finger movements.
    Stegemöller EL; Zadikoff C; Rosenow JM; Mackinnon CD
    Neurosci Lett; 2013 Sep; 552():135-9. PubMed ID: 23941889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson's disease.
    Choi JH; Kim HJ; Lee JY; Yoo D; Im JH; Paek SH; Jeon B
    PLoS One; 2019; 14(8):e0221219. PubMed ID: 31454366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the local field potential signal from the subthalamic nucleus for phase-targeted auditory stimulation in Parkinson's disease.
    Krugliakova E; Karpovich A; Stieglitz L; Huwiler S; Lustenberger C; Imbach L; Bujan B; Jedrysiak P; Jacomet M; Baumann CR; Fattinger S
    Brain Stimul; 2024 Jun; 17(4):769-779. PubMed ID: 38906529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical activity levels in people with Parkinson's disease treated by subthalamic nucleus deep brain stimulation.
    Danoudis M; Iansek R
    Disabil Rehabil; 2023 Sep; 45(18):2890-2895. PubMed ID: 36124542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep spindles in Parkinson's disease may predict the development of dementia.
    Latreille V; Carrier J; Lafortune M; Postuma RB; Bertrand JA; Panisset M; Chouinard S; Gagnon JF
    Neurobiol Aging; 2015 Feb; 36(2):1083-90. PubMed ID: 25442116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An infant sleep electroencephalographic marker of thalamocortical connectivity predicts behavioral outcome in late infancy.
    Jaramillo V; Schoch SF; Markovic A; Kohler M; Huber R; Lustenberger C; Kurth S
    Neuroimage; 2023 Apr; 269():119924. PubMed ID: 36739104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study.
    Kurcova S; Bardon J; Vastik M; Vecerkova M; Frolova M; Hvizdosova L; Nevrly M; Mensikova K; Otruba P; Krahulik D; Kurca E; Sivak S; Zapletalova J; Kanovsky P
    Medicine (Baltimore); 2018 Feb; 97(5):e9750. PubMed ID: 29384860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease.
    Dafsari HS; Ray-Chaudhuri K; Ashkan K; Sachse L; Mahlstedt P; Silverdale M; Rizos A; Strack M; Jost ST; Reker P; Samuel M; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Timmermann L;
    J Neurol; 2020 Jun; 267(6):1830-1841. PubMed ID: 32152689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson's Disease Patients.
    Bosch TJ; Cole RC; Bezchlibnyk Y; Flouty O; Singh A
    J Parkinsons Dis; 2023; 13(4):549-561. PubMed ID: 37092236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-frequency STN-DBS provides acute gait improvements in Parkinson's disease: a double-blinded randomised cross-over feasibility trial.
    Conway ZJ; Silburn PA; Perera T; O'Maley K; Cole MH
    J Neuroeng Rehabil; 2021 Aug; 18(1):125. PubMed ID: 34376190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsubthalamotomy improves sleep in patients affected by advanced Parkinson's disease.
    Merlino G; Lettieri C; Mondani M; Belgrado E; Devigili G; Mucchiut M; Rinaldo S; Craighero C; D'Auria S; Skrap M; Eleopra R
    Sleep Med; 2014 Jun; 15(6):637-41. PubMed ID: 24784787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of heart rate and blood pressure variability in Parkinson's disease patients after bilateral subthalamic deep brain stimulation].
    Furgała A; Górecka-Mazur A; Fiszer U; Pietraszko W; Thor P; Moskała M; Potasz K; Bukowczan M; Polak J; Krygowska-Wajs A
    Przegl Lek; 2015; 72(5):246-52. PubMed ID: 26817327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of bilateral stimulation of the subthalamic nucleus in Parkinson's disease with and without REM sleep behaviour disorder.
    Bargiotas P; Debove I; Bargiotas I; Lachenmayer ML; Ntafouli M; Vayatis N; Schüpbach MW; Krack P; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1310-1316. PubMed ID: 31422368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subthalamic nucleus deep brain stimulation changes velopharyngeal control in Parkinson's disease.
    Hammer MJ; Barlow SM; Lyons KE; Pahwa R
    J Commun Disord; 2011; 44(1):37-48. PubMed ID: 20708741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined Subthalamic and Nigral Stimulation Modulates Temporal Gait Coordination and Cortical Gait-Network Activity in Parkinson's Disease.
    Wagner JR; Schaper M; Hamel W; Westphal M; Gerloff C; Engel AK; Moll CKE; Gulberti A; Pötter-Nerger M
    Front Hum Neurosci; 2022; 16():812954. PubMed ID: 35295883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep outcomes and related factors in Parkinson's disease after subthalamic deep brain electrode implantation: a retrospective cohort study.
    Ma R; Yin Z; Chen Y; Yuan T; An Q; Gan Y; Xu Y; Jiang Y; Du T; Yang A; Meng F; Zhu G; Zhang J
    Ther Adv Neurol Disord; 2023; 16():17562864231161163. PubMed ID: 37200769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.